Metabolite Management System

• US 20100256466A1
• Filed: 04/02/2010
• Published: 10/07/2010
• Est. Priority Date: 04/02/2009
• Status: Abandoned Application

• Current Assignee: G-Sense Ltd.
• Original Assignee: G-Sense Ltd.
• Inventors: Zeltser, Carmel, Shekalim, Avraham, Peleg, Noam
• Application Number:
  US12/753,143
• Publication Number:
  US 20100256466A1
• Time in Patent Office: Days
• US Class Current: 600/317
• CPC Class Codes: A61B 5/14525 using microdialysis
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2005/14252 with needle insertion means
• CPC Class Codes: A61M 2005/1726 the body parameters being measured at, or proximate to, the infusion site
• CPC Class Codes: A61M 2205/3306 Optical measuring means
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/14248 of the skin patch type
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

A metabolite monitoring system configured to deliver drugs and obtain metabolite samples via one common skin perforation and measure metabolite content by way of an optical measuring-cell having a primary flow-path of constant cross-sectional area.

Claims

1. A system for managing a metabolite in a body of a patient comprising:

(a) a drug-delivery unit including a cannula configured for insertion into the body; and

(b) a metabolite-monitoring unit including a sampling probe configured for insertion into the body, said drug-delivery unit and said metabolite-monitoring unit being disposed in a housing such that said cannula and said sampling probe are in close proximity to each other thereby enabling their insertion into the body via one common skin perforation.

2. The system for managing a metabolite in a body of a patient of claim 1, wherein said sampling probe is threaded through at least one perforation in a wall of said cannula.

3. The system of claim 1, further comprising a control unit deployed to control said drug-delivery unit and said metabolite-monitoring unit, said control unit being configured to:

(a) actuate said drug-delivery unit to deliver separate dosages of a drug to the patient;

each of said dosages being separated by an interval of time; and

(b) actuate said metabolite-monitoring unit to obtain a metabolite sample from the patient after a minimum time delay following any one of said dosages sufficient for the metabolite sample to be indicative of an overall metabolite content in the body of the patient.

4. The system of claim 1, wherein said metabolite-monitoring unit includes a layered, optical-measuring-cell.

5. The system of claim 4, wherein said layered, optical-measuring-cell includes a primary flow path of constant cross-sectional area.

35. The system of claim 1, wherein said sampling probe is selected from the group consisting of a microdialysis fiber, electrochemical probe, fiber-optic sensor, and fiber-coupled fluorescence affinity sensor.

6. A method for managing a metabolite in a body of a patient comprising:

(a) providing a combined drug delivery and metabolite measurement system having a cannula and a metabolite sampling probe disposed in close proximity to each other so as to enable their insertion into the body via one common skin perforation; and

(b) inserting said cannula and said metabolite sampling probe into the body via one common skin perforation.

7. The method for managing a metabolite of claim 6, further comprising:

(a) delivering separate dosages of a drug to the patient, each of said dosages being separated by an interval of time;

(b) obtaining a metabolite sample from the patient after a minimum time delay following any one of said dosages sufficient for the metabolite sample to be indicative of an overall metabolite content in the body of the patient.

8. The method for managing a metabolite of claim 7, wherein said metabolite sampling probe includes a looped microdialysis sampling probe.

9. The method for managing a metabolite of claim 7, wherein said metabolite-measurement system includes a layered optical measuring-cell.

10. The method for managing a metabolite a metabolite of claim 9, wherein said layered optical measuring-cell includes a primary flow path having a substantially constant cross-sectional area between any two points along said flow path.

11. The method for managing a metabolite a metabolite of claim 10, wherein said metabolite sampling probe includes a looped microdialysis sampling probe.

12. A method for managing a metabolite in a body of a patient comprising:

(a) providing a combined drug delivery and metabolite measurement system;

(b) delivering separate dosages of a drug to the patient, each of said dosages being separated by an interval of time; and

(c) obtaining a metabolite sample from the patient after a minimum time delay following any one of said dosages sufficient for the metabolite sample to be indicative of an overall metabolite content in the body of the patient.

13. The method for managing a metabolite a metabolite of claim 12, wherein said combined drug delivery and metabolite measurement system includes a cannula and a metabolite sampling probe disposed in close proximity to each other so as to enable their insertion into the body via one common skin perforation.

14. The method for managing a metabolite a metabolite of claim 12 further comprising inserting said cannula and said metabolite sampling probe into the body via one common skin perforation.

15. The method for managing a metabolite a metabolite of claim 12, wherein said metabolite sampling probe includes a looped microdialysis sampling probe.

16. The method for managing a metabolite a metabolite of claim 12, wherein said metabolite-measurement system includes a layered optical measuring-cell.

17. The method for managing a metabolite a metabolite of claim 16, wherein said layered optical measuring-cell includes a primary flow path having a substantially constant cross-sectional area between any two points along said flow path.

18. The method for managing a metabolite a metabolite of claim 17, wherein said metabolite sampling probe includes a looped microdialysis sampling probe.

19. An optical measuring-cell for use with a metabolite monitoring unit that employs an optical sensor with a light source deployed for illuminating a measurement region, the optical measuring-cell comprising:

(a) a sheet of material having a groove defining a flow path passing through the measurement region illuminated by the light source, a portion of said groove within the measurement region being configured in a geometrical arrangement having a length at least 1.5 times greater than a maximum dimension of the measurement region; and

(b) at least one sheet of transparent material bonded to said sheet of material so as to enclose said groove defining a flow path thereby ensuring sufficient liquid is exposed to said light source to facilitate accurate optical measurements.

20. The optical measuring-cell of claim 19, wherein said at least one sheet of transparent material is implemented as two sheets, each of said two sheets being bonded to opposing faces of said sheet wherein said groove defining a flow path is at least partially implemented as a slot.

21. The optical measuring-cell of claim 19, wherein said flow path includes a flow path having a substantially constant cross-sectional area not varying more than 20% between any two points along the length of said flow path.

22. The optical measuring-cell of claim 19, wherein said sheet of material includes a sheet of aluminum.

23. The optical measuring-cell of claim 19, wherein said geometric arrangement includes a plurality of curves.

24. The optical measuring-cell of claim 19, wherein said geometric arrangement includes a spiral.

25. The optical measuring-cell of claim 19, wherein the length of said flow path is at least two times greater than a maximum dimension of said area illuminated by said light source.

26. The optical measuring-cell of claim 19, wherein the length of said flow path is at least 3 times greater than a maximum dimension of said area illuminated by said light source.

27. The optical measuring-cell of claim 19, wherein said groove extends outside said area illuminated by a light source so as to define a flow path upstream from said area illuminated by said light source to enable uniform mixing of dialysate and reagent prior to exposure to said light source.

28. A layered, optical measuring-cell partially illuminated by a light source for a metabolite-monitoring unit comprising:

(a) a sheet of material having a groove defining an illuminated flow-path segment in fluid connection with a non-illuminated flow-path segment wherein a cross-sectional area of said illuminated flow-path segment substantially matches a cross-sectional area of said non-illuminated flow-path segment thereby facilitating uniform flow from said non-illuminated, flow-path segment to said illuminated, flow-path segment.

29. The layered, optical measuring-cell of claim 28, wherein said illuminated flow-path segment has a geometrical arrangement of a length at least 1.5 times greater than a maximum dimension of an area of illuminated by the light source.

30. The optical measuring-cell of claim 28, wherein said illuminated flow-path segment has a geometrical arrangement of a length at least two times greater than a maximum dimension of an area of illuminated by the light source.

31. The optical measuring-cell of claim 28, wherein said illuminated flow path-segment has a geometrical arrangement of a length at least three times greater than a maximum dimension of an area of illuminated by the light source.

32. The layered optical measuring-cell of claim 28, wherein said geometric arrangement includes a plurality of curves.

33. The optical measuring-cell of claim 28, wherein said geometric arrangement includes a spiral.

34. The layered optical measuring-cell of claim 28, wherein said illuminated flow-path segment being disposed in a first plane and said non-illuminated flow-path segment being disposed in a second plane wherein said first plane is different from said second plane.